期刊
MOLECULES
卷 19, 期 7, 页码 9307-9317出版社
MDPI
DOI: 10.3390/molecules19079307
关键词
N-alkyl carbazole derivatives; Alzheimer's disease; amyloid beta-peptide
资金
- Programma Operativo Nazionale (PON) Ricerca e Competivita per le regioni della Convergenza [2007IT161PO006]
- Commissione Europea, Fondo Sociale Europeo
- Regione Calabria
- FARB, University of Salerno
Alzheimer's disease (AD) is a progressive and age-related neurodegenerative disorder affecting brain cells and is the most common form of dementia, because of the cognitive detriment which takes place. Neuronal disruption represents its major feature, due to the cytosolic accumulation of amyloid beta-peptide (A beta) which leads to senile plaques formation and intracellular neurofibrillary tangles. Many studies have focused on the design and therapeutic use of new molecules able to inhibit A beta aggregation. In this context, we evaluated the ability of two recently synthesized series of N-alkyl carbazole derivatives to increase the A beta soluble forms, through molecular docking simulations and in vitro experiments. Our data evidenced that two carbazole derivatives, the most active, adopt distinct binding modes involving key residues for A beta fibrillization. They exhibit a good interfering activity on A beta aggregation in mouse (N2a) cells, stably expressing wild-type human amyloid precursor protein (APP) 695. These preliminary results are promising and we are confident that the N-alkyl carbazole derivatives may encourage next future studies needed for enlarging the knowledge about the AD disease approach.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据